Medtronic (MDT) income statement
NYSE · Healthcare · Medical - Devices · 95,000 employees · CEO Geoffrey Straub Martha
- Price
- $96.54 -0.59%
- Market cap
- $123B
- Enterprise value
- $150B
- Last report
- Q1 '27 filed 2026-09-03
- Next report
- 2026-11-17 EPS est. $1.33
Medtronic (MDT) reported revenue of $9.76B for Q1 '27 (+13.7% year on year), operating income of $1.76B (18.1% of revenue) and net income of $1.47B. Over the last four quarters revenue was $37.5B.
Income statement
| Income statement | Trend | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.98B | $8.09B | $8.59B | $7.92B | $8.4B | $8.29B | $8.93B | $8.58B | $8.96B | $9.02B | $9.81B | $9.76B | |
| Cost of revenue | $2.76B | $2.78B | $3.04B | $2.76B | $2.95B | $2.78B | $3.15B | $3.63B | $3.56B | $3.17B | $2.37B | $3.42B | |
| Gross profit | $5.22B | $5.31B | $5.55B | $5.15B | $5.46B | $5.51B | $5.78B | $4.95B | $5.41B | $5.85B | $7.44B | $6.34B | |
| Research & development | $698M | $695M | $675M | $676M | $697M | $675M | $684M | $726M | $754M | $722M | $671M | $771M | |
| Other operating expenses | $499M | $456M | $1.05B | $545M | $408M | $475M | $940M | -$31M | $0 | $401M | $2.15B | $607M | |
| Operating expenses | $3.88B | $3.82B | $4.49B | $3.88B | $3.86B | $3.87B | $4.34B | $3.5B | $3.72B | $4.08B | $5.88B | $4.58B | |
| Operating income | $1.34B | $1.48B | $1.05B | $1.28B | $1.6B | $1.65B | $1.44B | $1.45B | $1.69B | $1.77B | $1.56B | $1.76B | |
| Interest income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $33M | $0 | $121M | -$154M | $0 | |
| Interest expense | $180M | $188M | $202M | $167M | $209M | $179M | $174M | $176M | $181M | $181M | $177M | $186M | |
| Other non-operating income (gains on investments, FX ...) | -$153M | -$177M | -$4M | -$157M | -$173M | -$73M | $1M | -$32M | -$92M | $188M | -$448M | -$191M | |
| Total non-operating income | -$27M | -$11M | -$197M | -$10M | -$36M | -$106M | -$175M | -$143M | -$89M | -$369M | $270M | $5M | |
| Income before tax | $1.31B | $1.47B | $856M | $1.27B | $1.56B | $1.54B | $1.26B | $1.3B | $1.6B | $1.4B | $1.83B | $1.77B | |
| Income tax | $402M | $135M | $197M | $220M | $281M | $237M | $199M | $255M | $215M | $254M | $575M | $289M | |
| Net income | $909M | $1.32B | $654M | $1.04B | $1.27B | $1.29B | $1.06B | $1.04B | $1.37B | $1.14B | $1.24B | $1.47B | |
| EPS (basic) | $0.68 | $0.99 | $0.49 | $0.81 | $0.99 | $1.01 | $0.82 | $0.81 | $1.07 | $0.89 | $0.98 | $1.15 | |
| EPS (diluted) | $0.68 | $0.99 | $0.49 | $0.80 | $0.99 | $1.01 | $0.82 | $0.81 | $1.07 | $0.89 | $0.96 | $1.14 | |
| Shares (basic, weighted) | 1.33B | 1.33B | 1.32B | 1.29B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | |
| Shares (diluted, weighted) | 1.33B | 1.33B | 1.33B | 1.3B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | |
| Depreciation & amortization | $672M | $649M | $654M | $662M | $675M | $684M | $840M | $748M | $745M | $749M | $625M | $729M | |
| EBITDA | $2.17B | $2.31B | $1.71B | $2.1B | $2.44B | $2.4B | $2.28B | $2.23B | $2.52B | $2.33B | $2.64B | $2.68B |
| Income statement | Trend | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29.7B | $30B | $30.6B | $28.9B | $30.1B | $31.7B | $31.2B | $32.4B | $33.5B | $36.4B | |
| Cost of revenue | $9.29B | $9.07B | $9.16B | $9.42B | $10.5B | $10.1B | $10.7B | $11.2B | $11.6B | $12.7B | |
| Gross profit | $20.4B | $20.9B | $21.4B | $19.5B | $19.6B | $21.5B | $20.5B | $21.1B | $21.9B | $23.6B | |
| Research & development | $2.19B | $2.26B | $2.33B | $2.33B | $2.49B | $2.75B | $2.7B | $2.74B | $2.73B | $2.87B | |
| Other operating expenses | $2.82B | $1.75B | $2.39B | $2.26B | $2.51B | $2.75B | $1.91B | $2.53B | $2.37B | $2.52B | |
| Operating expenses | $15B | $14.2B | $15.1B | $14.7B | $15.2B | $15.8B | $15B | $16B | $16B | $17.2B | |
| Operating income | $5.38B | $6.64B | $6.27B | $4.79B | $4.48B | $5.75B | $5.49B | $5.14B | $5.96B | $6.47B | |
| Interest expense | $1.09B | $1.15B | $1.44B | $1.09B | $925M | $553M | $636M | $719M | $729M | $715M | |
| Other non-operating income (gains on investments, FX ...) | -$313M | -$181M | -$373M | -$356M | -$336M | -$318M | -$515M | -$412M | -$402M | -$384M | |
| Total non-operating income | -$781M | -$965M | -$1.07B | -$736M | -$589M | -$235M | -$121M | -$307M | -$327M | -$331M | |
| Income before tax | $4.6B | $5.68B | $5.2B | $4.06B | $3.9B | $5.52B | $5.36B | $4.84B | $5.63B | $6.14B | |
| Income tax | $578M | $2.58B | $547M | -$751M | $265M | $456M | $1.58B | $1.13B | $936M | $1.3B | |
| Net income | $4.03B | $3.1B | $4.63B | $4.79B | $3.61B | $5.04B | $3.76B | $3.68B | $4.66B | $4.8B | |
| EPS (basic) | $2.92 | $2.29 | $3.44 | $3.57 | $2.68 | $3.75 | $2.83 | $2.77 | $3.63 | $3.75 | |
| EPS (diluted) | $2.89 | $2.27 | $3.41 | $3.54 | $2.66 | $3.73 | $2.82 | $2.76 | $3.61 | $3.73 | |
| Shares (basic, weighted) | 1.38B | 1.36B | 1.35B | 1.34B | 1.34B | 1.34B | 1.33B | 1.33B | 1.29B | 1.28B | |
| Shares (diluted, weighted) | 1.39B | 1.37B | 1.36B | 1.35B | 1.35B | 1.35B | 1.33B | 1.33B | 1.29B | 1.29B | |
| Depreciation & amortization | $2.92B | $2.64B | $2.66B | $2.66B | $2.7B | $2.71B | $2.7B | $2.65B | $2.86B | $2.96B | |
| EBITDA | $8.61B | $9.47B | $9.3B | $7.81B | $7.52B | $8.78B | $8.7B | $8.2B | $9.22B | $9.81B |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-07-31, 10-K 2026-04-24, 10-Q 2026-01-23, 10-Q 2025-10-24, 10-Q 2025-07-25, 10-K 2025-04-25, 10-Q 2025-01-24, 10-Q 2024-10-25
Not updated in the last refresh (older data or none shown): SEC segments.
Data as of 2026-11-01